Clinical Trial Update: Introducing Biosimilar Insulin Glargine to the Treatment Regimen of Children and Youth with Type 1 Diabetes in Mali [Phase 4]

View source ↗

Summary

Phase 4 trial in Mali completed evaluating a biosimilar insulin glargine added to the treatment regimen for children and youths with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• insulin glargine biosimilar (insulin glargine)

Snippet

Sponsor: Life for a Child Program, Diabetes Australia | Conditions: Type 1 Diabetes (T1D) | Phase 4 | Status: COMPLETED